Related Experiment Video

Updated: May 25, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms

Erika M Lisabeth1, Carlos Fernandez, Elena B Pasquale

  • 1Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States.

Biochemistry
|January 17, 2012
PubMed

Insights

EphA3 receptor tyrosine kinase mutations disrupt its tumor-suppressing activities in various cancers. These mutations impair kinase function and cell surface localization, suggesting EphA3 acts as a tumor suppressor.

Area of Science:

  • Molecular Biology
  • Oncology
  • Signal Transduction

Background:

  • Eph receptor tyrosine kinases (RTKs) are crucial for cellular processes like adhesion, movement, shape, and growth, all relevant to cancer progression.
  • The precise role of Eph receptors in cancer is complex and not fully elucidated.
  • Somatic mutations in Eph receptors have been identified in various human tumors, with EphA3 being the most frequently mutated.

Purpose of the Study:

  • To investigate the functional consequences of EphA3 mutations found in human cancers.
  • To determine if EphA3 possesses tumor-suppressing activities and how mutations affect these functions.

Main Methods:

  • Analysis of EphA3 mutations identified in lung, colorectal, hepatocellular cancers, melanoma, and glioblastoma.
  • Assessment of kinase activity, ephrin ligand binding, and cell surface localization of mutated EphA3 receptors.

Main Results:

  • Many identified EphA3 mutations impair its kinase activity.
  • Several mutations were found to disrupt ephrin ligand binding.
  • Mutations frequently decrease the level of EphA3 receptor cell surface localization.

Conclusions:

  • EphA3 exhibits tumor-suppressing activities that are dependent on its kinase function and ephrin binding.
  • Somatic mutations identified in various cancers disrupt these tumor-suppressing functions of EphA3.
  • Understanding these disruptions may offer insights into cancer development and potential therapeutic strategies.

More Related Videos

Three-Dimensional (3D) Tumor Spheroid Invasion Assay12:19

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...